Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb:235:106398.
doi: 10.1016/j.prevetmed.2024.106398. Epub 2024 Dec 3.

Overweight and obese body condition in ∼4.9 million dogs and ∼1.3 million cats seen at primary practices across the USA: Prevalences by life stage from early growth to senior

Affiliations
Free article

Overweight and obese body condition in ∼4.9 million dogs and ∼1.3 million cats seen at primary practices across the USA: Prevalences by life stage from early growth to senior

Mathieu Montoya et al. Prev Vet Med. 2025 Feb.
Free article

Abstract

Adult dogs and cats in overweight or obese condition are common, but prevalence data for different life stages, especially growth, are limited, and may help inform when preventative measures may be most effective. In this retrospective observational study, prevalences of overweight and obese condition were determined from the electronic medical records of dogs and cats of all life stages visiting Banfield Pet Hospital in the USA between 2020 and 2023. Animals were identified either by body condition score (BCS; overweight 6-7; obese 8-9) or from a clinical diagnosis of overweight condition or obesity when recorded. Life stages (early growth, late growth, young adult, adult, mature, and senior) were defined by age range, adjusted for species and breed size in dogs. Individuals could only be included once within each life stage, with the maximum BCS used. Prevalence was determined for the 4-year period and for each calendar year. The evolution of BCS was also assessed for animals with multiple records. In total, 4933,916 unique dogs and 1341,118 unique cats were included. In dogs, prevalences of overweight or obese condition were: 0.9 % and < 0.0 % (early growth), 9.5 % and 0.3 % (late growth), 24.4 % and 1.9 % (young adult); 44.5 % and 8.4 % (adult), 50.1 % and 12.6 % (mature); 46.4 % and 11.3 % (senior). In cats, prevalences of overweight or obese condition were: 0.8 % and < 0.0 % (early growth); 10.7 % and 0.4 % (late growth); 36.2 % and 3.6 % (young adult); 47.2 % and 13.9 % (adult); 44.8 % and 21.7 % (mature); and 32.0 % and 12.6 % (senior). From 2020-2021 and 2021-2022 prevalences of overweight and obese condition in dogs and overweight condition in cats increased in most life stages. The prevalence of overweight condition in dogs and obese condition in cats and dogs significantly decreased between 2022 and 2023 for some life stages. The odds ratio of an overweight or obese condition in adulthood was 1.85 (95 % confidence interval [CI]: 1.81, 1.86); P ≤ 0.001) for dogs and 1.52 (95 % CI: 1.48, 1.56; P ≤ 0.001) for cats where an overweight or obese condition was recorded during growth. In conclusion, both overweight and obese condition are prevalent throughout adult life, peaking during the mature life stage in dogs and cats, with overweight or obese condition during growth persisting into adulthood in most affected animals. Veterinarian-led prevention strategies are recommended from growth onwards, including the use of growth standard charts.

Keywords: Adiposity; Canine; Feline; Kitten; Life stage; Puppy.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Alex J German reports financial support was provided by Royal Canin. JF, MM, TH, FP and VG are employees of Royal Canin SAS. JM is an employee Mars Veterinary Health. AJG is an employee of the University of Liverpool, but his post is financially supported by Royal Canin. AJG has also received financial remuneration for providing educational material, speaking at conferences, and consultancy work from Royal Canin. Royal Canin SAS and Mars Veterinary Health are subsidiaries of Mars Inc. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

Publication types

LinkOut - more resources